Interferon-Beta Improves Survival in Enterovirus-Associated Cardiomyopathy

被引：112

作者：

Kuehl, Uwe ^{[1
]}

Lassner, D. ^{[1
]}

von Schlippenbach, Jessica ^{[1
]}

Poller, Wolfgang ^{[1
]}

Schultheiss, Heinz-Peter ^{[1
]}

机构：

[1] Charite, Charite Ctr Cardiovasc Med 11, Dept Cardiol & Pneumol, D-12200 Berlin, Germany

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 60卷 / 14期

关键词：

PERSISTENCE; DYSFUNCTION; MYOCARDITIS;

D O I：

10.1016/j.jacc.2012.06.026

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1295 / 1296

页数：2

共 5 条

[1] Medical Progress: Myocarditis. [J].

Cooper, Leslie T., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (15) :1526-1538

[2] Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system [J].

Kandolf, R ;

Sauter, M ;

Aepinus, C ;

Schnorr, JJ ;

Selinka, HC ;

Klingel, K .

VIRUS RESEARCH, 1999, 62 (02) :149-158

[3] Viral persistence in the myocardium is associated with progressive cardiac dysfunction [J].

Kühl, U ;

Pauschinger, M ;

Seeberg, B ;

Lassner, D ;

Noutsias, M ;

Poller, W ;

Schultheiss, HPP .

CIRCULATION, 2005, 112 (13) :1965-1970

[4] Interferon-β treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction [J].

Kühl, U ;

Pauschinger, M ;

Schwimmbeck, PL ;

Seeberg, B ;

Lober, C ;

Noutsias, M ;

Poller, W ;

Schultheiss, HP .

CIRCULATION, 2003, 107 (22) :2793-2798

[5] CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF DETECTION OF ENTEROVIRAL RNA IN THE MYOCARDIUM OF PATIENTS WITH MYOCARDITIS OR DILATED CARDIOMYOPATHY [J].

WHY, HJF ;

MEANY, BT ;

RICHARDSON, PJ ;

OLSEN, EGJ ;

BOWLES, NE ;

CUNNINGHAM, L ;

FREEKE, CA ;

ARCHARD, LC .

CIRCULATION, 1994, 89 (06) :2582-2589

← 1 →